|
SPECIFICATION
SHEET
Sodium Chondroitin Sulfate
from Bovine
Cartilage
Meets USP
Specifications
|
Test
Procedure |
Min. |
Max. |
Test Method |
Bioburden
Salmonella*
E.
coli*
APC*
S.
aureus
Molds/yeast*
|
0
0
0
0
0
|
0 cfu/25 g
0
cfu/g
1000 cfu/g
0
cfu/g
100
cfu/g
|
FDA BAM/USP
FDA BAM/USP
FDA BAM/USP
FDA
BAM/USP
FDA BAM/USP
|
| Bulk Density |
0.50
g/mL |
0.75
g/mL |
USP |
| Chloride Limit* |
0 |
0.5% |
USP |
| Clarity/Color* |
0 |
0.35
Abs. |
USP |
| CPC* |
90% |
105% |
USP |
| Electrophoresis* |
0 |
1% |
USP |
| Heavy Metals* |
0 |
0.002% |
USP |
|
Identification*
Infrared Absorbance
Sodium |
Pass/Fail
Pass/Fail
|
|
USP
USP
|
| Lead |
0 |
<0.5
ppm |
USP |
| Loss on Drying* |
0 |
10% |
USP |
| Organic Volatile
impurities* |
0 |
600
ug/g |
USP |
| Optical Rotation* |
-20 |
-30 |
USP |
| pH* |
5.5 |
7.5 |
USP
|
| Powder Fineness |
99.9% |
- |
Modified
USP |
| Protein* |
0% |
6.0% |
USP |
| Residue on Ignition* |
20% |
30% |
USP |
| Solution Solubility |
Soluble |
- |
USP
|
| Sulfate* |
0 |
0.24% |
USP |
* Tests
required
for USP. |
|
|
|
Copyrightã 2003 Sioux
Pharm, Inc.
All rights Reserved | 
